ZB
GEVA

Zions Bancorporation’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Zions Bancorporation’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7
Closed -$1K – 918
2015
Q1 		$1K Buy
+7
New +$741 ﹤0.01% 921

Zions Bancorporation's GEVA Position: Q2 2015 in Review

Zions Bancorporation sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 7 shares — an estimated $1K sold.

Zions Bancorporation first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $1K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Zions Bancorporation reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Zions Bancorporation sold 7 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1K.
  • Zions Bancorporation first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Zions Bancorporation's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Zions Bancorporation's 13F filing for Q2 2015, filed 13 Aug 2015.